--- description: Clinical study design. Select and classify endpoints, estimate sample size / power (means / proportions / survival), and score a study plan for a GO / GO-WITH-CONDITIONS / REDESIGN / NO-GO phase-gate decision. Every output is an ESTIMATE plus a named clinical owner — never clinical fact. Direct invocation of the clinical-research skill. argument-hint: "" --- # /cs:clinical-research — Endpoint selection + sample-size + phase-gate feasibility Run the `clinical-research` skill on this input: **$ARGUMENTS** ## Three-tool workflow 1. **`endpoint_selector.py`** — Score candidate endpoints across clinical relevance, measurability, regulatory acceptance, sensitivity-to-change, and burden. Classify PRIMARY / KEY-SECONDARY / EXPLORATORY. Flags unvalidated surrogates (cannot be primary). Industry tuning via `--profile`. 2. **`sample_size_estimator.py`** — Closed-form power / sample size for two-arm means (Cohen's d), proportions (normal approx), or survival (Schoenfeld events). Inflates for dropout. The effect/difference/HR must trace to a published or anchor-based source. 3. **`phase_gate_scorer.py`** — Score the study plan 0-100 across recruitment feasibility, endpoint readiness, statistical power, operational complexity, and budget fit. Verdict + named owners (PI, Medical Monitor, Biostatistician, Regulatory Owner). ## Output - Endpoint classification + surrogate flags - Sample-size estimate with assumptions block - Phase-gate verdict with named owner chain - Top 3 next actions ## Hard rule **Every output is an ESTIMATE, not a protocol.** A biostatistician, medical monitor, and regulatory owner sign the final design. ## First run + optimization - **Onboard first:** `python3 skills/clinical-research/scripts/onboard.py` (area, alpha, power, dropout, named owners) — saved config pre-configures every tool. `--show` lists the questions. - **Optimize (opt-in):** only if the user asks to optimize/run a loop, hand off to autoresearch via `skills/clinical-research/scripts/ar_evaluator.py` (`feasibility_composite`, higher is better). ## Distinct from - `ra-qm-team` — that's the regulatory **submission**. This designs the **study**. - `research/grants` — that **finds funding**. This **designs the trial**. - `product-team/experiment-designer` — that's a **product A/B**. This is a **clinical trial**.